Author

Chloe M. Hasund

Observed names: Chloe Hasund, Chloe M Hasund, Hasund, Chloe

Institutions: Broad Institute, National Institutes of Health, Harvard University, National Institute of Allergy and Infectious Diseases, Massachusetts Institute of Technology

Observed institutions: Broad Institute, National Institutes of Health, Harvard University, Cornell University, National Institute of Allergy and Infectious Diseases, Massachusetts Institute of Technology

ORCID: 0009-0009-3513-562X

Observed ORCID: 0009-0009-3513-562X

OpenAlex ID: A5092002277

Primary exposure to Zika virus is linked with increased risk of symptomatic dengue virus infection with serotypes 2, 3, and 4, but not 1

2024 · Jose Victor Zambrana, Chloe M. Hasund, et al. · Science Translational Medicine · 55

Placental Erythroferrone and Erythropoietin mRNA Expression is not Associated with Maternal or Neonatal Iron Status in Adolescents Carrying Singletons and Adult Women Carrying Multiples

2023 · Katherine M Delaney, Alexa Barad, et al. · Journal of Nutrition · 3

Phase 1 trial to model primary, secondary, and tertiary dengue using a monovalent vaccine

2023 · Camila D. Odio, Kelsey E. Lowman, et al. · BMC Infectious Diseases · 3

PvGTSeq and PvCRiSP: two amplicon-based targeted sequencing panels for Plasmodium vivax

2025 · Paulo C. Manrique-Valverde, Chloe M. Hasund, et al. · medRxiv · 1

Association of asymptomatic Plasmodium falciparum infections and its treatment with short-term cognitive performance in school-aged children: A prospective cohort study in western Kenya

2026 · Megan S. McHenry, George Ayodo, et al. · Journal of Infection

Investigating features of dengue immunity that drive enhancement versus protection 2307730

2026 · Nhyira Asante, Rosemary Aogo, et al. · The Journal of Immunology

Cytokine, plasmablast, and clinical biomarker profiles following monovalent dengue vaccination in individuals with distinct immune histories 2308784

2026 · Keerthi Konda, Kelsey Lowman, et al. · The Journal of Immunology

Post-infection immune response in adults with COVID-19 with and without nirmatrelvir-ritonavir treatment and virologic rebound

2026 · Dibya Ghimire, Chloe M. Hasund, et al. · bioRxiv (Cold Spring Harbor Laboratory)

PvGTSeq and PvCRiSP: Two amplicon-based targeted sequencing panels for Plasmodium vivax

2026 · Paulo C. Manrique-Valverde, Chloe M. Hasund, et al. · PLoS neglected tropical diseases

Enhancing, controlling, and sterilizing dengue immunity and the development of broadly protective responses

2026 · Camila D. Odio, Rosemary A. Aogo, et al. · medRxiv

Immunity to Non-Dengue Flaviviruses Impacts Dengue Virus Immunoglobulin G Enzyme-Linked Immunosorbent Assay Specificity in Cambodia

2024 · Camila D Odio, Christina Yek, et al. · The Journal of Infectious Diseases

Immunity to non-dengue flaviviruses impacts dengue virus IgG ELISA specificity in Cambodia

2023 · Camila Odio, Christina Yek, et al. · medRxiv

Works count: 13

Citation count: 62

H-index: 3

I10-index: 1